Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Bosutinib

Related Products

Hot Products

Name

Bosutinib

EINECS 700-455-1
CAS No. 380843-75-4 Density 1.36 g/cm3
PSA 82.88000 LogP 5.13918
Solubility N/A Melting Point 116-120 °C
Formula C26H29Cl2N5O3 Boiling Point 649.7 °C at 760 mmHg
Molecular Weight 530.454 Flash Point 346.7 °C
Transport Information N/A Appearance white powder
Safety 26 Risk Codes 36
Molecular Structure Molecular Structure of 380843-75-4 (Bosutinib) Hazard Symbols Xi
Synonyms

4-[(2,4-dichloro-5-methoxy-phenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile;3-Quinolinecarbonitrile, 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-;Bosutinib [USAN];4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile;SKI-606;Bosutinib(TINIBS );

Article Data 17

Bosutinib Specification

1. Introduction of Bosutinib
Bosutinib is one kind of white powder. The IUPAC Name of it is 4-(2,4-Dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile. It belongs to API;Aromatics Compounds. It may in EP Standard or Standard Enterprise. The Classification Code of it is Antineoplastic (Src kinase inhibitor); Antineoplastic Agents; Antineoplastic [Src kinase inhibitor].

2. Properties of Bosutinib
Physical properties about Bosutinib are:
(1)Index of Refraction: 1.651; (2)Density: 1.36 g/cm3; (3)Flash Point: 346.7 °C; (4)Melting point: 116-120 °C; (5)Enthalpy of Vaporization: 95.77 kJ/mol; (6)Boiling Point: 649.7 °C at 760 mmHg; (7)Vapour Pressure: 9.15E-17 mmHg at 25 °C.

3. Structure Descriptors of Bosutinib
(1)InChI: InChI=1S/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31)
(2)InChIKey: InChIKey=UBPYILGKFZZVDX-UHFFFAOYSA-N
(3)Smiles: c1(cc2ncc(C#N)c(Nc3cc(OC)c(Cl)cc3Cl)c2cc1OC)OCCCN1CCN(CC1)C

4. Uses of Bosutinib
Bosutinib (CAS NO.380843-75-4) has been used for API. It is a tyrosine kinase inhibitor undergoing research for use in the treatment of CML. It is also used in the treatment of cancer use in the treatment of cancer. Some commercial stocks of bosutinib have recently been found to have the incorrect chemical structure, calling the biological results obtained with them into doubt.
 

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 380843-75-4